Herbert Yu

23.1k total citations · 2 hit papers
254 papers, 12.1k citations indexed

About

Herbert Yu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Herbert Yu has authored 254 papers receiving a total of 12.1k indexed citations (citations by other indexed papers that have themselves been cited), including 126 papers in Molecular Biology, 77 papers in Cancer Research and 72 papers in Oncology. Recurrent topics in Herbert Yu's work include Growth Hormone and Insulin-like Growth Factors (47 papers), Cancer-related molecular mechanisms research (40 papers) and RNA modifications and cancer (30 papers). Herbert Yu is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (47 papers), Cancer-related molecular mechanisms research (40 papers) and RNA modifications and cancer (30 papers). Herbert Yu collaborates with scholars based in United States, China and Italy. Herbert Yu's co-authors include Lingeng Lu, Dionyssios Katsaros, Biyun Qian, Harvey A. Risch, Melinda L. Irwin, Xiaomei Ma, Irene A. Rigault de la Longrais, Thomas Rutherford, Hans J. Berkel and Susan T. Mayne and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Herbert Yu

249 papers receiving 11.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression

2000 1.2k citations Herbert Yu profile →
A G3BP1-Interacting lncRNA Promotes Ferroptosis and Apoptosis in Cancer via Nuclear Sequestration of p53

2018 402 citations Chao Mao, Xiang Wang et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Herbert Yu United States	62	6.0k	3.6k	3.6k	2.1k	1.4k	254	12.1k
Paola Muti United States	64	3.9k 0.6×	2.4k 0.7×	3.4k 1.0×	1.5k 0.7×	1.3k 0.9×	253	12.2k
Pamela J. Goodwin Canada	61	4.9k 0.8×	2.7k 0.8×	6.9k 1.9×	1.2k 0.6×	1.8k 1.3×	172	12.2k
Qiuyin Cai United States	58	5.6k 0.9×	2.3k 0.6×	2.5k 0.7×	931 0.4×	938 0.7×	398	12.8k
Marc J. Gunter France	55	2.9k 0.5×	1.8k 0.5×	2.9k 0.8×	1.1k 0.5×	751 0.5×	299	11.3k
June M. Chan United States	53	3.3k 0.6×	2.2k 0.6×	3.3k 0.9×	3.2k 1.5×	3.3k 2.4×	203	13.1k
Rudolf Kaaks Germany	70	4.9k 0.8×	3.2k 0.9×	6.2k 1.7×	2.9k 1.4×	2.0k 1.5×	308	18.2k
Robert B. Clarke United Kingdom	54	5.6k 0.9×	2.6k 0.7×	5.8k 1.6×	796 0.4×	1.1k 0.8×	168	13.7k
Franco Berrino Italy	73	3.4k 0.6×	2.8k 0.8×	7.6k 2.1×	1.9k 0.9×	2.3k 1.7×	310	18.1k
Mimi C. Yu United States	71	4.6k 0.8×	2.0k 0.6×	3.1k 0.9×	784 0.4×	1.4k 1.0×	205	14.5k
Jonas Manjer Sweden	52	2.2k 0.4×	2.4k 0.7×	3.7k 1.0×	1.0k 0.5×	1.5k 1.1×	220	8.9k

Countries citing papers authored by Herbert Yu

Since Specialization

Citations

This map shows the geographic impact of Herbert Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herbert Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herbert Yu more than expected).

Fields of papers citing papers by Herbert Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Herbert Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herbert Yu. The network helps show where Herbert Yu may publish in the future.

Co-authorship network of co-authors of Herbert Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Herbert Yu. A scholar is included among the top collaborators of Herbert Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Herbert Yu. Herbert Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kumar, Sudhir, Wei Du, Jun Zhang, et al.. (2024). Somatic gene mutations involved in DNA damage response/Fanconi anemia signaling are tissue- and cell-type specific in human solid tumors. Frontiers in Medicine. 11. 1462810–1462810. 1 indexed citations

Yang, Xiaochun, Kazufumi Ohshiro, Patricia S. Latham, et al.. (2024). 459 REGULATION OF CEACAM1 IN METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS (MASH) AND HCC BY TGF-β SIGNALING. Gastroenterology. 166(5). S–1547. 1 indexed citations

Li, Qiang, Weituo Zhang, Tian Liao, et al.. (2024). An Artificial Intelligence–Driven Preoperative Radiomic Subtype for Predicting the Prognosis and Treatment Response of Patients with Papillary Thyroid Carcinoma. Clinical Cancer Research. 31(1). 139–150. 2 indexed citations

Wang, Suna, Li Xie, Ying Qian, et al.. (2023). Association between use of antihypertensive drugs and the risk of cancer: a population-based cohort study in Shanghai. BMC Cancer. 23(1). 425–425. 4 indexed citations

Bantum, Erin O’Carroll, Paulette M. Yamada, Herbert Yu, et al.. (2023). Hula as a physical activity and social support intervention for sustained activity in female breast and gynecologic cancer survivors. Frontiers in Psychology. 14. 1190532–1190532. 1 indexed citations

Zhong, Hua, et al.. (2023). Elucidating the role of blood metabolites on pancreatic cancer risk using two‐sample Mendelian randomization analysis. International Journal of Cancer. 154(5). 852–862. 12 indexed citations

Furuya, Hideki, Steve Goodison, Ian Pagano, et al.. (2023). Association of SNPs in the PAI1 Gene with Disease Recurrence and Clinical Outcome in Bladder Cancer. International Journal of Molecular Sciences. 24(5). 4943–4943. 4 indexed citations

Merritt, Melissa A., Howard D. Strickler, Alan D. Hutson, et al.. (2021). Sex Hormones, Insulin, and Insulin-like Growth Factors in Recurrence of High-Stage Endometrial Cancer. Cancer Epidemiology Biomarkers & Prevention. 30(4). 719–726. 10 indexed citations

Jung, Su Yon, Peter Scott, Jeanette C. Papp, et al.. (2020). Genome-wide Association Analysis of Proinflammatory Cytokines and Gene–lifestyle Interaction for Invasive Breast Cancer Risk: The WHI dbGaP Study. Cancer Prevention Research. 14(1). 41–54. 15 indexed citations

10.

Jiang, Runqiu, Xiaojiao Zheng, Sha Lei, et al.. (2019). Ursodeoxycholic acid accelerates bile acid enterohepatic circulation. British Journal of Pharmacology. 176(16). 2848–2863. 65 indexed citations

11.

Jung, Su Yon, Jeanette C. Papp, Eric M. Sobel, Herbert Yu, & Zuo‐Feng Zhang. (2019). Breast Cancer Risk and Insulin Resistance: Post Genome-Wide Gene–Environment Interaction Study Using a Random Survival Forest. Cancer Research. 79(10). 2784–2794. 19 indexed citations

12.

Mao, Chao, Xiang Wang, Yating Liu, et al.. (2018). A G3BP1-Interacting lncRNA Promotes Ferroptosis and Apoptosis in Cancer via Nuclear Sequestration of p53. Cancer Research. 78(13). 3484–3496. 402 indexed citations breakdown →

13.

Huang, Huang, Jennifer A. Rusiecki, Nan Zhao, et al.. (2017). Thyroid-Stimulating Hormone, Thyroid Hormones, and Risk of Papillary Thyroid Cancer: A Nested Case–Control Study. Cancer Epidemiology Biomarkers & Prevention. 26(8). 1209–1218. 64 indexed citations

14.

Risch, Harvey A., Lingeng Lu, Jing Wang, et al.. (2016). Aspirin Use and Reduced Risk of Pancreatic Cancer. Cancer Epidemiology Biomarkers & Prevention. 26(1). 68–74. 50 indexed citations

15.

Kim, Wonnam, Farzin M. Takyar, Karena Swan, et al.. (2016). Calcium-Sensing Receptor Promotes Breast Cancer by Stimulating Intracrine Actions of Parathyroid Hormone–Related Protein. Cancer Research. 76(18). 5348–5360. 49 indexed citations

16.

McWilliams, Robert R., Patrick Maisonneuve, William R. Bamlet, et al.. (2015). Risk Factors for Early-Onset and Very-Early-Onset Pancreatic Adenocarcinoma. Pancreas. 45(2). 311–316. 93 indexed citations

17.

Xue, Xiaonan, Xianhong Xie, Marc J. Gunter, et al.. (2013). Testing the proportional hazards assumption in case-cohort analysis. BMC Medical Research Methodology. 13(1). 88–88. 107 indexed citations

18.

Zhang, Huan, et al.. (2012). Meta-Analysis of the Association between Mir-196a-2 Polymorphism and Cancer Susceptibility. SHILAP Revista de lepidopterología. 18 indexed citations

19.

Visintin, Irene, Ziding Feng, Gary Longton, et al.. (2008). Diagnostic Markers for Early Detection of Ovarian Cancer. Clinical Cancer Research. 14(4). 1065–1072. 307 indexed citations

20.

Dai, Qi, Adrian A. Franke, Herbert Yu, et al.. (2003). Urinary Phytoestrogen Excretion and Breast Cancer Risk. Cancer Epidemiology and Prevention Biomarkers. 12(6). 497–502. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact